Norges Bank Immunic, Inc. Transaction History
Norges Bank
- $736 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
51.2MCall Options Held
824KPut Options Held
354K-
Bvf Inc San Francisco, CA8.9MShares$9.97 Million0.33% of portfolio
-
Avidity Partners Management LP Dallas, TX7.97MShares$8.92 Million0.9% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$8.17 Million0.51% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$5.12 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.92MShares$4.39 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $34.2M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...